Furthermore, SOP-Phos-DIA demonstrated robustcoverage to reveal a complex interplay of Hippo signaling, EGFR-TKIsignaling, and ERBB signaling, which are likely involved in the TKI-resistancemechanism in lung cancer cells. The gene discussed is EGFR; the disease is lung carcinoma.